—Even long after the active phase of thyroid eye disease has subsided, a multitude of challenging quality-of-life issues may persist. Several recent studies have established that the physical ...
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced new pooled efficacy data from the Phase 2 and 3 clinical trials of TEPEZZA™ (teprotumumab-trbw) showing that the ...
“I’m just so tired.” “I don’t know where this extra weight came from.” “My eyes look like they’re bulging.” Is your thyroid to blame? Widespread myths about the thyroid make it challenging to know for ...
DUBLIN--(BUSINESS WIRE)--For Graves’ Disease Awareness Month in July, Horizon Therapeutics plc (Nasdaq: HZNP) is teaming up with world-renowned track star and three-time Olympic gold medalist Gail ...
Please provide your email address to receive an email when new articles are posted on . Veligrotug improved proptosis, diplopia and clinical activity score in patients with active or chronic thyroid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results